These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials? Rizik DG; Hermiller JB; Simonton CA; Klassen KJ; Kereiakes DJ Coron Artery Dis; 2017 Jan; 28(1):77-89. PubMed ID: 27561169 [TBL] [Abstract][Full Text] [Related]
25. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound. Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845 [TBL] [Abstract][Full Text] [Related]
26. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial. Gao R; Yang Y; Han Y; Huo Y; Chen J; Yu B; Su X; Li L; Kuo HC; Ying SW; Cheong WF; Zhang Y; Su X; Xu B; Popma JJ; Stone GW; J Am Coll Cardiol; 2015 Dec; 66(21):2298-2309. PubMed ID: 26471805 [TBL] [Abstract][Full Text] [Related]
27. Percutaneous Coronary Intervention With Bioresorbable Scaffolds in a Young Child. Nazif TM; Kalra S; Ali ZA; Karmpaliotis D; Turner ME; Starc TJ; Cao Y; Marboe CC; Collins MB; Leon MB; Kirtane AJ JAMA Cardiol; 2017 Apr; 2(4):430-434. PubMed ID: 28030655 [TBL] [Abstract][Full Text] [Related]
28. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry. La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959 [TBL] [Abstract][Full Text] [Related]
29. When and how to use BRS in bifurcations? Stankovic G; Lassen JF EuroIntervention; 2015; 11 Suppl V():V185-7. PubMed ID: 25983163 [TBL] [Abstract][Full Text] [Related]
30. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Bennett J; Adriaenssens T; Desmet W; Dubois C Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586 [TBL] [Abstract][Full Text] [Related]
31. Long-term results of BVS implantation: a focus on safety and efficacy of the bioresorbable technology. DEN Dekker WK; VAN Geuns RJ; Diletti R Minerva Cardioangiol; 2016 Aug; 64(4):462-72. PubMed ID: 27175976 [TBL] [Abstract][Full Text] [Related]
32. Bioresorbable Scaffold With Drug-Coated Balloon: A "Biodegradable" Model for Bifurcation Lesions Treatment. The New Intriguing Chapter of the "Leaving Nothing Behind" Saga. Buccheri D; Piraino D; Andolina G Am J Cardiol; 2016 Jul; 118(2):308-9. PubMed ID: 27206913 [No Abstract] [Full Text] [Related]
35. Bioresorbable vascular scaffolds: Time to absorb past lessons or fade away? de Pommereau A; de Hemptinne Q; Varenne O; Picard F Arch Cardiovasc Dis; 2018 Apr; 111(4):229-232. PubMed ID: 29678390 [No Abstract] [Full Text] [Related]
36. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel. Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653 [No Abstract] [Full Text] [Related]
37. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment. Gil RJ; Bil J; Pawłowski T; Yuldashev N; Kołakowski L; Jańczak J; Jabłoński W; Paliński P Kardiol Pol; 2016; 74(7):627-33. PubMed ID: 26779846 [TBL] [Abstract][Full Text] [Related]
38. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds. Ielasi A; Tespili M Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477 [TBL] [Abstract][Full Text] [Related]
39. Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology. Chamié D; Garcia-Garcia H; Costa RA; Onuma Y; Abizaid A; Serruys PW Catheter Cardiovasc Interv; 2016 Nov; 88(S1):38-53. PubMed ID: 27797463 [TBL] [Abstract][Full Text] [Related]
40. Bioresorbable vascular scaffold in patients with complex coronary artery disease. Tamburino CI; Capranzano P; Longo G; Immè S; Tamburino G; Scalia M; Condorelli A; Francaviglia B; LA Manna A; Sgroi C; Grasso C; DI Salvo ME; Capodanno D; Tamburino C Minerva Cardioangiol; 2016 Aug; 64(4):481-6. PubMed ID: 27128353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]